Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 9/2009

01.09.2009 | Basic Science

Kinetics of retinal vaso-obliteration and neovascularisation in the oxygen-induced retinopathy (OIR) mouse model

verfasst von: C. Lange, C. Ehlken, A. Stahl, G. Martin, L. Hansen, H. T. Agostini

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the kinetics of peripheral vascularisation, central vessel regression and neovascularisation in the OIR mouse model in order to: i) generate standard kinetics for further studies in this model, and ii) define optimal time points to investigate cellular mechanisms of retinal vascular plasticity.

Methods

From postnatal day 7 (P7) until P12, newborn mice were kept at 75% oxygen. The animals were sacrificed on different time points, during and after O2 exposure. After intracardial perfusion with FITC–dextran, retinal flatmounts were prepared, and the size of the retinal vascular network, the size of the central avascular area, and the number of blood vessel tufts and clusters were determined. In addition to the fluorescein stain for perfused capillaries, endothelial cells were stained with isolectin.

Results

Upon O2 exposure, there is a rapid depletion of capillaries starting adjacent to the large central arteries. These avascular stripes fuse to form an avascular central area which amounts to 37% of the whole retinal surface after 2 days of hyperoxia. The peripheral capillary network remains intact throughout the incubation period, even though the pace of its centrifugal spreading is decelerated compared to room air controls. Already during O2 exposure, revascularisation of the central avascular area is initiated by peripheral vessels sprouting in a centripetal direction. Revascularisation is accelerated after the return to room air, and is completed at P25. Maximal pathological neovascularisation can be found at P17, at the border between the avascular and vascular retina.

Conclusion

Hyperoxia leads to a rapid development of a central avascular area of the retina, with its maximum during not at the end of the hyperoxic phase. Central capillary loss and peripheral vascularisation take place simultaneously, indicating different cellular control mechanisms for different areas of the retina. These standard kinetics for peripheral vascularisation and central vessel regression will: 1) help to compare the effects of angio-modulation, and 2) serve as normal baseline for the characterization of knock-out mice strains with regard to gene-specific vascular changes in the OIR-model.
Literatur
2.
Zurück zum Zitat Kahn HA, Hiller R (1974) Blindness caused by diabetic retinopathy. Am J Ophthalmol 78:58–67PubMed Kahn HA, Hiller R (1974) Blindness caused by diabetic retinopathy. Am J Ophthalmol 78:58–67PubMed
4.
Zurück zum Zitat Hofman P, van Blijswijk BC, Gaillard PJ, Vrensen GF, Schlingemann RO (2001) Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion. Arch Ophthalmol 119:861–866PubMed Hofman P, van Blijswijk BC, Gaillard PJ, Vrensen GF, Schlingemann RO (2001) Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion. Arch Ophthalmol 119:861–866PubMed
7.
Zurück zum Zitat Apte RS, Modi M, Masonson H, Patel M, Whitfield L, Adamis AP (2007) Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration. Ophthalmology 114:1702–1712, doi:10.1016/j.ophtha.2007.02.021 PubMedCrossRef Apte RS, Modi M, Masonson H, Patel M, Whitfield L, Adamis AP (2007) Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration. Ophthalmology 114:1702–1712, doi:10.​1016/​j.​ophtha.​2007.​02.​021 PubMedCrossRef
8.
Zurück zum Zitat Colquitt JL, Jones J, Tan SC, Takeda A, Clegg AJ, Price A (2008) Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess 12:iii-201PubMed Colquitt JL, Jones J, Tan SC, Takeda A, Clegg AJ, Price A (2008) Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess 12:iii-201PubMed
11.
Zurück zum Zitat Moradian S, Ahmadieh H, Malihi M, Soheilian M, Dehghan MH, Azarmina M (2008) Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 246:1699–1705, doi:10.1007/s00417-008-0914-4 PubMedCrossRef Moradian S, Ahmadieh H, Malihi M, Soheilian M, Dehghan MH, Azarmina M (2008) Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 246:1699–1705, doi:10.​1007/​s00417-008-0914-4 PubMedCrossRef
13.
Zurück zum Zitat Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101–111PubMed Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101–111PubMed
14.
15.
Zurück zum Zitat Lange C, Ehlken C, Martin G, Konzok K, Del Moscoso PJ, Hansen LL, Agostini HT (2007) Intravitreal injection of the heparin analog 5-amino-2-naphthalenesulfonate reduces retinal neovascularization in mice. Exp Eye Res 85:323–327, doi:10.1016/j.exer.2007.05.007 PubMedCrossRef Lange C, Ehlken C, Martin G, Konzok K, Del Moscoso PJ, Hansen LL, Agostini HT (2007) Intravitreal injection of the heparin analog 5-amino-2-naphthalenesulfonate reduces retinal neovascularization in mice. Exp Eye Res 85:323–327, doi:10.​1016/​j.​exer.​2007.​05.​007 PubMedCrossRef
16.
Zurück zum Zitat Rabinowitz R, Katz G, Rosner M, Pri-Chen S, Spierer A (2008) The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 246:843–848, doi:10.1007/s00417-008-0781-z PubMedCrossRef Rabinowitz R, Katz G, Rosner M, Pri-Chen S, Spierer A (2008) The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 246:843–848, doi:10.​1007/​s00417-008-0781-z PubMedCrossRef
17.
Zurück zum Zitat Maier P, Unsoeld AS, Junker B, Martin G, Drevs J, Hansen LL, Agostini HT (2005) Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice. Graefes Arch Clin Exp Ophthalmol 243:593–600, doi:10.1007/s00417-004-1021-9 PubMedCrossRef Maier P, Unsoeld AS, Junker B, Martin G, Drevs J, Hansen LL, Agostini HT (2005) Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice. Graefes Arch Clin Exp Ophthalmol 243:593–600, doi:10.​1007/​s00417-004-1021-9 PubMedCrossRef
18.
Zurück zum Zitat Unsoeld AS, Junker B, Mazitschek R, Martin G, Hansen LL, Giannis A, Agostini HT (2004) Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice. Mol Vis 10:468–475PubMed Unsoeld AS, Junker B, Mazitschek R, Martin G, Hansen LL, Giannis A, Agostini HT (2004) Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice. Mol Vis 10:468–475PubMed
21.
Zurück zum Zitat Uusitalo-Jarvinen H, Kurokawa T, Mueller BM, Andrade-Gordon P, Friedlander M, Ruf W (2007) Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis. Arterioscler Thromb Vasc Biol 27:1456–1462, doi:10.1161/ATVBAHA.107.142539 PubMedCrossRef Uusitalo-Jarvinen H, Kurokawa T, Mueller BM, Andrade-Gordon P, Friedlander M, Ruf W (2007) Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis. Arterioscler Thromb Vasc Biol 27:1456–1462, doi:10.​1161/​ATVBAHA.​107.​142539 PubMedCrossRef
22.
Zurück zum Zitat Gardiner TA, Gibson DS, de Gooyer TE, de la Cruz VF, McDonald DM, Stitt AW (2005) Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am J Pathol 166:637–644PubMed Gardiner TA, Gibson DS, de Gooyer TE, de la Cruz VF, McDonald DM, Stitt AW (2005) Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am J Pathol 166:637–644PubMed
24.
Zurück zum Zitat Dorrell MI, Aguilar E, Friedlander M (2002) Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific r-cadherin adhesion. Invest Ophthalmol Vis Sci 43:3500–3510PubMed Dorrell MI, Aguilar E, Friedlander M (2002) Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific r-cadherin adhesion. Invest Ophthalmol Vis Sci 43:3500–3510PubMed
25.
Zurück zum Zitat Shen J, Xie B, Hatara CM, Hackett SF, Campochiaro PA (2007) Vegf or EphA2 antisense polyamide-nucleic acids; vascular localization and suppression of retinal neovascularization. Mol Ther 15:1924–1930, doi:10.1038/sj.mt.6300276 PubMedCrossRef Shen J, Xie B, Hatara CM, Hackett SF, Campochiaro PA (2007) Vegf or EphA2 antisense polyamide-nucleic acids; vascular localization and suppression of retinal neovascularization. Mol Ther 15:1924–1930, doi:10.​1038/​sj.​mt.​6300276 PubMedCrossRef
27.
Zurück zum Zitat Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, Keshet E (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15:4738–4747PubMed Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, Keshet E (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15:4738–4747PubMed
28.
Zurück zum Zitat Pierce EA, Foley ED, Smith LE (1996) Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 114:1219–1228PubMed Pierce EA, Foley ED, Smith LE (1996) Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 114:1219–1228PubMed
29.
Zurück zum Zitat McLeod DS, Taomoto M, Cao J, Zhu Z, Witte L, Lutty GA (2002) Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 43:474–482PubMed McLeod DS, Taomoto M, Cao J, Zhu Z, Witte L, Lutty GA (2002) Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 43:474–482PubMed
30.
Zurück zum Zitat Gu X, El-Remessy AB, Brooks SE, Al-Shabrawey M, Tsai NT, Caldwell RB (2003) Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. Am J Physiol Cell Physiol 285:C546–C554PubMed Gu X, El-Remessy AB, Brooks SE, Al-Shabrawey M, Tsai NT, Caldwell RB (2003) Hyperoxia induces retinal vascular endothelial cell apoptosis through formation of peroxynitrite. Am J Physiol Cell Physiol 285:C546–C554PubMed
31.
Zurück zum Zitat Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024–1028, doi:10.1038/nm1095-1024 PubMedCrossRef Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024–1028, doi:10.​1038/​nm1095-1024 PubMedCrossRef
33.
Zurück zum Zitat Benjamin LE, Hemo I, Keshet E (1998) A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125:1591–1598PubMed Benjamin LE, Hemo I, Keshet E (1998) A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125:1591–1598PubMed
34.
Zurück zum Zitat Ashton N (1957) Retinal vascularization in health and disease: proctor award lecture of the association for research in ophthalmology. Am J Ophthalmol 44:7–17PubMed Ashton N (1957) Retinal vascularization in health and disease: proctor award lecture of the association for research in ophthalmology. Am J Ophthalmol 44:7–17PubMed
Metadaten
Titel
Kinetics of retinal vaso-obliteration and neovascularisation in the oxygen-induced retinopathy (OIR) mouse model
verfasst von
C. Lange
C. Ehlken
A. Stahl
G. Martin
L. Hansen
H. T. Agostini
Publikationsdatum
01.09.2009
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 9/2009
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-009-1116-4

Weitere Artikel der Ausgabe 9/2009

Graefe's Archive for Clinical and Experimental Ophthalmology 9/2009 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.